Mini-MEST Test Method for Reducing Animal and Compound Usage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for evaluating the pro- or anti-convulsive properties of test compounds, such as the maximal electroshock seizure threshold (MEST) test, require a large number of animals and significant amounts of test compounds, lacking a streamlined approach to quickly determine efficacy while accounting for various experimental factors.
Innovation Solution
The mini-MEST test method involves dosing a reduced number of animals with a test compound or control, assessing tonic hind limb extensor convulsions with a single electroshock at a defined current, and adjusting the current in a logarithmic scale to determine the CC50 value, allowing for a clear indication of anticonvulsant properties with less test compound and animal usage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the standard MEST test is used to evaluate pro- or anti-convulsive properties, then reliable results can be obtained, but a large number of animals (at least 12) and significant amounts of test compound are required
Solution Approach 1:
The patent applies segmentation by dividing the conventional MEST test into a simplified 'mini-MEST' version. Instead of using the full standard protocol with 12+ animals, the test is segmented to use only 6-8 animals per group while maintaining evaluation reliability through optimized dosing strategies and refined observation criteria.
Solution Approach 2:
The patent changes key parameters of the MEST test, specifically reducing the number of animals from 12 to 6-8 per group, and modifying the dosing approach to require significantly less test compound. These parameter changes maintain the test's ability to reliably distinguish pro- and anti-convulsive properties while reducing resource requirements.
2Reliability
If the standard MEST test is used, then comprehensive evaluation of test compounds can be performed, but the process is time-consuming and requires large amounts of test compound
Solution Approach 1:
The patent applies partial action by implementing a streamlined version of the MEST test that performs the essential evaluation functions with reduced resources. The mini-MEST test uses fewer animals and less compound while still providing comprehensive enough data for preclinical assessment, accepting that some minor details of the full protocol are simplified.
Solution Approach 2:
The patent modifies time-related parameters by reducing the number of animals and simplifying the protocol steps, which directly decreases the total testing time required. The optimized design allows for faster completion of each test group while maintaining evaluation comprehensiveness for determining convulsive properties.
3Productivity
If a reduced number of animals is used in the MEST test, then animal usage is minimized, but the statistical reliability of results may be compromised
Solution Approach 1:
The patent changes the sample size parameter from the conventional 12+ animals to an optimized range of 6-8 animals per group. This parameter change is accompanied by adjustments in dosing strategies and data analysis approaches that compensate for the smaller sample size, maintaining statistical reliability while improving productivity and reducing animal usage.
4Reliability
If the conventional MEST test procedure is followed, then thorough assessment can be conducted, but the complexity of the procedure increases
Solution Approach 1:
The patent extracts and removes unnecessary complexity from the conventional MEST test procedure. The mini-MEST version retains the essential assessment components for evaluating convulsive properties while eliminating redundant steps and simplifying the overall protocol, making the procedure easier to perform without sacrificing assessment thoroughness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mini-MEST test provides robust and efficient preliminary results, reducing the number of animals and test compound required, while offering a clear binary indication of anticonvulsant activity, thus streamlining the preclinical assessment process.
Implementation Method 1
individually assessing the treated animals for the production of a tonic hind limb extensor convulsion at a defined period of time post-dose from a single electroshock at a defined current
Data Source
AI summary
The present invention relates to a method of evaluating the pro- or anti convulsive properties of test compounds that is both streamlined and is capable of providing a clear indication for the selection of candidate compounds during preclinical assessment.